Summary Information:
Biolase Inc. Common Stock
NASDAQ:BIOL


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Biolase Inc. Common Stock
Exchange: NASDAQ
Symbol: BIOL
SEC CIK: 0000811240
Phone: 949-361-1200
27042 TOWNE CENTRE DRIVE
SUITE 270
FOOTHILL RANCH CA 92610
CEO: Todd Norbe
Price when page updated: 1.13 Date: 2023-11-30
Company Website:
www.biolase.com

_Description: BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

IPO YEAR:

Sector:
Health Care
Industry:
Medical/Dental Instruments
ADRTSO:

MarketCap:
2595358.00
Beta:
1.338964960885233
52 Week High:
1.51
52 Week Low:
0.37
52 Week Change:
0.03810775295663604
Short Interest:

Short Date:

Shares Outstanding:
153279540
Dividend Rate:
0
Dividend Yield:
0.00%
ExDividend Date:

Latest EPS:

Latest EPS Date:
14 Nov 2022
Float:
0
return on Equity:
-
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
-0.1322
Revenue:
$423.264M
Gross Profit:

Cash:

Debt:

Institution Percent:
48.50%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.70%
Return on Assets:
-
Return on Capital:

Profit Margin:
-
Price to Sales:
-
Price To Book:
2.74
Short Ratio:
3.96
PE Ratio:
-3.4500779702547155
Employees:
135
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Biolase Inc. Common Stock [ BIOL ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30